While Biohaven Ltd has overperformed by 0.75%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BHVN fell by -64.23%, with highs and lows ranging from $55.70 to $13.24, whereas the simple moving average fell by -58.98% in the last 200 days.
On May 19, 2025, RBC Capital Mkts Downgraded Biohaven Ltd (NYSE: BHVN) to Sector Perform. A report published by Deutsche Bank on February 11, 2025, Initiated its previous ‘Buy’ rating for BHVN. Jefferies also rated BHVN shares as ‘Buy’, setting a target price of $57 on the company’s shares in an initiating report dated September 16, 2024. Bernstein Initiated an Outperform rating on September 04, 2024, and assigned a price target of $55. Morgan Stanley initiated its ‘Overweight’ rating for BHVN, as published in its report on July 24, 2024. RBC Capital Mkts’s report from February 16, 2024 suggests a price prediction of $62 for BHVN shares, giving the stock a ‘Outperform’ rating. UBS also rated the stock as ‘Buy’.
Analysis of Biohaven Ltd (BHVN)
In order to gain a clear picture of Biohaven Ltd’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -316.82% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.33, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 2.17M can be a very valuable indicator of volatility for BHVN stock. On a monthly basis, the volatility of the stock is set at 5.13%, whereas on a weekly basis, it is put at 5.70%, with a loss of -7.73% over the past seven days. Furthermore, long-term investors anticipate a median target price of $54.21, showing growth from the present price of $13.36, which can serve as yet another indication of whether BHVN is worth investing in or should be passed over.
How Do You Analyze Biohaven Ltd Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 12.68%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 88.83% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
BHVN shares are owned by institutional investors to the tune of 88.83% at present.
